IRCT20151120025139N2
Recruiting
N/A
Evaluation of diagnostic accuracy and side effects of endometrial biopsy curette, a product of Slamtyar Hakim Engineering Company
Salamat yar Hakim Engineering Company0 sites60 target enrollmentTBD
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- terine endometrial biopsy.
- Sponsor
- Salamat yar Hakim Engineering Company
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age range 75\-18
- •Willingness to participate in the study
Exclusion Criteria
- •History of endometrial cancer
- •History of atypical endometrial hyperplasia
- •Positive pregnancy test result
- •Reluctance to participate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
accuracy evaluation of digital navigation implant systemNot ApplicableKCT0005465Yonsei University Health System, Dental Hospital60
Recruiting
N/A
The diagnostic accuracy and treatment evaluation of the patients with outdoor activity or Severe fever with thrombocytopenia syndromeCertain infectious and parasitic diseasesKCT0005114Chosun University Hospital250
Recruiting
N/A
Diagnostic performance and prognostic significance of myocardial pathological findings in cardiomyopathycardiomyopathyJPRN-UMIN000041174Department of Cardiovascular Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University900
Not Yet Recruiting
N/A
Evaluation of diagnostic test and curative effect for the superficial bladder cancer based oral 5-aminolevulinic acid (5-ALA) prior to transurethral resection (TUR)JPRN-UMIN000035009Dokkyo Medical University, Department of Urology500
Active, Not Recruiting
Phase 1
Diagnostic efficacy and prognostic method [18F] DOPA-PET/CT instudy of neuroblastoma: comparison with 123I-MIBG scintigraphypatients wiht NB onset with high probability to return in stages 3 and 4 of the disease on the basis of the ultrasound images or TC. May also be included with the two-stage amplification of N-MYCMedDRA version: 14.1Level: PTClassification code 10029260Term: NeuroblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-005398-30-ITAZIENDA OSPEDALIERA OSPEDALI GALLIERA40